These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17915274)

  • 21. Cell resensitization after delivery of a cycle-specific anticancer drug and effect of dose splitting: learning from tumour cords.
    Bertuzzi A; Fasano A; Gandolfi A; Sinisgalli C
    J Theor Biol; 2007 Feb; 244(3):388-99. PubMed ID: 17074361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormesis without cell killing.
    Cox LA
    Risk Anal; 2009 Mar; 29(3):393-400. PubMed ID: 18793280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
    Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M
    Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of likely cancer cure using first- and second-order product densities of population balance models.
    Sherer E; Hannemann RE; Rundell A; Ramkrishna D
    Ann Biomed Eng; 2007 Jun; 35(6):903-15. PubMed ID: 17440813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular mechanism of cell death induced by chemotherapeutic agents].
    Saya H
    Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the cancer stem cell population "a player" in multi-drug resistance?
    Drewa T; Styczynski J; Szczepanek J
    Acta Pol Pharm; 2008; 65(4):493-500. PubMed ID: 19051593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming drug resistance in patients with metastatic breast cancer.
    Wong ST; Goodin S
    Pharmacotherapy; 2009 Aug; 29(8):954-65. PubMed ID: 19637949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines.
    Komuro H; Saihara R; Shinya M; Takita J; Kaneko S; Kaneko M; Hayashi Y
    J Pediatr Surg; 2007 Dec; 42(12):2040-5. PubMed ID: 18082704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels.
    Ghayad SE; Bieche I; Vendrell JA; Keime C; Lidereau R; Dumontet C; Cohen PA
    Cancer Sci; 2008 Oct; 99(10):1992-2003. PubMed ID: 19016759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of novel tumour-derived p53 mutations on the transformation of NIH-3T3 cells.
    Donninger H; Binder A; Bohm L; Parker MI
    Biol Chem; 2008 Jan; 389(1):57-67. PubMed ID: 18095870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?
    Sánchez-García I; Vicente-Dueñas C; Cobaleda C
    Bioessays; 2007 Dec; 29(12):1269-80. PubMed ID: 18022789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling of the stochastic dynamics of radiation cell death: general approaches and some applications.
    Kruglikov IL
    Radiat Res; 1992 Apr; 130(1):26-30. PubMed ID: 1561315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A stochastic model in tumor growth.
    Albano G; Giorno V
    J Theor Biol; 2006 Sep; 242(2):329-36. PubMed ID: 16620871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A stochastic model of a cell population with quiescence.
    Olofsson P
    J Biol Dyn; 2008 Oct; 2(4):386-91. PubMed ID: 22876904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extinction models for cancer stem cell therapy.
    Sehl M; Zhou H; Sinsheimer JS; Lange KL
    Math Biosci; 2011 Dec; 234(2):132-46. PubMed ID: 22001354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The probability of treatment induced drug resistance.
    Schinazi RB
    Acta Biotheor; 2006; 54(1):13-9. PubMed ID: 16823607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The first exploration of the properties and laws of mutation plastids transmitting with cell division].
    Wang F; Tang Z; Wang Z
    Yi Chuan Xue Bao; 1996; 23(3):234-42. PubMed ID: 8950852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quiescence as an explanation of Gompertzian tumor growth revisited.
    Alzahrani EO; Asiri A; El-Dessoky MM; Kuang Y
    Math Biosci; 2014 Aug; 254():76-82. PubMed ID: 24968353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.